JACQUELINE BROADWAY: Open Payments
NPI 1760569891 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,855 in 47 payments from 15 companies in 2025. Trend: 2023 $2,644 · 2024 $2,673 · 2025 $6,855
Speaker / faculty: $3,200Consulting: $2,338Food & beverage: $1,294Education: $23
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $3,296 |
| Eli Lilly and Company | 1 | $2,338 |
| AstraZeneca Pharmaceuticals LP | 8 | $244 |
| SOBI, INC | 6 | $187 |
| Syndax Pharmaceuticals, Inc. | 4 | $177 |
| Astellas Pharma US Inc | 5 | $159 |
| Novartis Pharmaceuticals Corporation | 4 | $129 |
| Azurity Pharmaceuticals, Inc. | 4 | $68 |
| ABBVIE INC. | 2 | $59 |
| Incyte Corporation | 2 | $50 |
Products named: JAYPIRCA, CALQUENCE, Vonjo, SCEMBLIX, Cresemba, DANZITEN, JAKAFI, clonoSEQ.
Industry payments across TX — which companies pay providers there.
